|
ZNF687 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.56839996335157E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.02500280169716E-11 |
| Normal-vs-Stage2 |
1.045720E-04 |
| Normal-vs-Stage3 |
7.943800E-02 |
| Normal-vs-Stage4 |
3.657400E-03 |
| Stage1-vs-Stage2 |
8.005600E-01 |
| Stage1-vs-Stage3 |
1.902210E-02 |
| Stage1-vs-Stage4 |
7.854000E-01 |
| Stage2-vs-Stage3 |
1.588950E-01 |
| Stage2-vs-Stage4 |
6.544200E-01 |
| Stage3-vs-Stage4 |
1.619250E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.72189998212968E-09 |
| Normal-vs-AfricanAmerican |
3.11340000447302E-08 |
| Normal-vs-Asian |
4.404400E-03 |
| Caucasian-vs-AfricanAmerican |
5.751200E-01 |
| Caucasian-vs-Asian |
9.461600E-01 |
| AfricanAmerican-vs-Asian |
9.039800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.19069976101116E-10 |
| Normal-vs-Female |
1.664070E-02 |
| Male-vs-Female |
5.861800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.26530000000591E-05 |
| Normal-vs-Extreme_Weight |
1.62839963735451E-10 |
| Normal-vs-Obese |
7.71450000000007E-05 |
| Normal-vs-Extreme_Obese |
4.15470000000306E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.702600E-01 |
| Normal_Weight-vs-Obese |
4.956200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.876000E-01 |
| Extreme_Weight-vs-Obese |
3.982000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.247600E-01 |
| Obese-vs-Extreme_Obese |
3.990000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.188560E-01 |
| Normal-vs-Age(41-60Yrs) |
2.41290000002614E-06 |
| Normal-vs-Age(61-80Yrs) |
1.99519956112226E-10 |
| Normal-vs-Age(81-100Yrs) |
1.76410000052307E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.884600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.280000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.002900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.534500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.032300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.084000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.27240004591067E-09 |
| Normal-VS-Type2 PRCC |
6.9269000002592E-07 |
| Normal-VS-KIRP CIMP |
1.603390E-01 |
| Normal-VS-Unclassified PRCC |
1.859600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.895000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.375400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.097000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.774800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.680390E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.882600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.99440000257101E-09 |
| Normal-vs-N1 |
2.720000E-01 |
| Normal-vs-N2 |
5.924000E-01 |
| N0-vs-N1 |
5.160100E-02 |
| N0-vs-N2 |
7.350100E-02 |
| N1-vs-N2 |
8.204400E-01 |
|
|
